Logo image of ALERS.PA

EUROBIO-SCIENTIFIC (ALERS.PA) Stock Fundamental Analysis

Europe - EPA:ALERS - FR0013240934 - Common Stock

25.2 EUR
-0.35 (-1.37%)
Last: 10/6/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALERS. ALERS was compared to 73 industry peers in the Biotechnology industry. ALERS gets an excellent profitability rating and is at the same time showing great financial health properties. ALERS is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, ALERS could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ALERS had positive earnings in the past year.
In the past year ALERS had a positive cash flow from operations.
In the past 5 years ALERS has always been profitable.
Each year in the past 5 years ALERS had a positive operating cash flow.
ALERS.PA Yearly Net Income VS EBIT VS OCF VS FCFALERS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.55%, ALERS is in the better half of the industry, outperforming 76.71% of the companies in the same industry.
Looking at the Return On Equity, with a value of 2.24%, ALERS is in the better half of the industry, outperforming 79.45% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.25%, ALERS belongs to the top of the industry, outperforming 80.82% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALERS is significantly below the industry average of 14.37%.
Industry RankSector Rank
ROA 1.55%
ROE 2.24%
ROIC 4.25%
ROA(3y)3.54%
ROA(5y)16.42%
ROE(3y)6.48%
ROE(5y)25.15%
ROIC(3y)5.13%
ROIC(5y)17.09%
ALERS.PA Yearly ROA, ROE, ROICALERS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

ALERS has a better Profit Margin (2.59%) than 79.45% of its industry peers.
In the last couple of years the Profit Margin of ALERS has declined.
ALERS has a better Operating Margin (8.81%) than 82.19% of its industry peers.
In the last couple of years the Operating Margin of ALERS has grown nicely.
ALERS's Gross Margin of 46.49% is in line compared to the rest of the industry. ALERS outperforms 53.42% of its industry peers.
In the last couple of years the Gross Margin of ALERS has grown nicely.
Industry RankSector Rank
OM 8.81%
PM (TTM) 2.59%
GM 46.49%
OM growth 3Y-38.55%
OM growth 5Y55.68%
PM growth 3Y-57.11%
PM growth 5Y-13.49%
GM growth 3Y-5.65%
GM growth 5Y7%
ALERS.PA Yearly Profit, Operating, Gross MarginsALERS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALERS is destroying value.
The number of shares outstanding for ALERS remains at a similar level compared to 1 year ago.
ALERS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ALERS has been reduced compared to a year ago.
ALERS.PA Yearly Shares OutstandingALERS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALERS.PA Yearly Total Debt VS Total AssetsALERS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ALERS has an Altman-Z score of 3.84. This indicates that ALERS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.84, ALERS belongs to the best of the industry, outperforming 82.19% of the companies in the same industry.
The Debt to FCF ratio of ALERS is 2.53, which is a good value as it means it would take ALERS, 2.53 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.53, ALERS belongs to the top of the industry, outperforming 89.04% of the companies in the same industry.
A Debt/Equity ratio of 0.17 indicates that ALERS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.17, ALERS is in the better half of the industry, outperforming 61.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.53
Altman-Z 3.84
ROIC/WACC0.6
WACC7.08%
ALERS.PA Yearly LT Debt VS Equity VS FCFALERS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.03 indicates that ALERS has no problem at all paying its short term obligations.
ALERS has a Current ratio of 2.03. This is comparable to the rest of the industry: ALERS outperforms 49.32% of its industry peers.
ALERS has a Quick Ratio of 1.42. This is a normal value and indicates that ALERS is financially healthy and should not expect problems in meeting its short term obligations.
ALERS has a Quick ratio (1.42) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.42
ALERS.PA Yearly Current Assets VS Current LiabilitesALERS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

7

3. Growth

3.1 Past

ALERS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.16%.
ALERS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.82% yearly.
ALERS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.40%.
ALERS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.21% yearly.
EPS 1Y (TTM)-59.16%
EPS 3Y-58.79%
EPS 5Y6.82%
EPS Q2Q%-34.78%
Revenue 1Y (TTM)12.4%
Revenue growth 3Y-5.77%
Revenue growth 5Y21.21%
Sales Q2Q%10.13%

3.2 Future

Based on estimates for the next years, ALERS will show a very strong growth in Earnings Per Share. The EPS will grow by 34.84% on average per year.
ALERS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.90% yearly.
EPS Next Y31.82%
EPS Next 2Y34.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.03%
Revenue Next 2Y12.9%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALERS.PA Yearly Revenue VS EstimatesALERS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
ALERS.PA Yearly EPS VS EstimatesALERS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 96.92, which means the current valuation is very expensive for ALERS.
Based on the Price/Earnings ratio, ALERS is valued a bit cheaper than 78.08% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALERS to the average of the S&P500 Index (27.90), we can say ALERS is valued expensively.
Based on the Price/Forward Earnings ratio of 15.29, the valuation of ALERS can be described as correct.
ALERS's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALERS is cheaper than 87.67% of the companies in the same industry.
ALERS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.36.
Industry RankSector Rank
PE 96.92
Fwd PE 15.29
ALERS.PA Price Earnings VS Forward Price EarningsALERS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALERS indicates a rather cheap valuation: ALERS is cheaper than 89.04% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ALERS is valued cheaply inside the industry as 84.93% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.21
EV/EBITDA 8.9
ALERS.PA Per share dataALERS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ALERS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ALERS's earnings are expected to grow with 34.84% in the coming years.
PEG (NY)3.05
PEG (5Y)14.22
EPS Next 2Y34.84%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALERS!.
Industry RankSector Rank
Dividend Yield N/A

EUROBIO-SCIENTIFIC

EPA:ALERS (10/6/2025, 7:00:00 PM)

25.2

-0.35 (-1.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-24 2025-09-24
Earnings (Next)N/A N/A
Inst Owners2.86%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap258.30M
Analysts84.44
Price Target30.6 (21.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)11.45%
Revenue NY rev (3m)11.45%
Valuation
Industry RankSector Rank
PE 96.92
Fwd PE 15.29
P/S 1.67
P/FCF 19.21
P/OCF 15.46
P/B 1.45
P/tB 10.26
EV/EBITDA 8.9
EPS(TTM)0.26
EY1.03%
EPS(NY)1.65
Fwd EY6.54%
FCF(TTM)1.31
FCFY5.21%
OCF(TTM)1.63
OCFY6.47%
SpS15.08
BVpS17.43
TBVpS2.46
PEG (NY)3.05
PEG (5Y)14.22
Profitability
Industry RankSector Rank
ROA 1.55%
ROE 2.24%
ROCE 6.39%
ROIC 4.25%
ROICexc 4.76%
ROICexgc 24.83%
OM 8.81%
PM (TTM) 2.59%
GM 46.49%
FCFM 8.7%
ROA(3y)3.54%
ROA(5y)16.42%
ROE(3y)6.48%
ROE(5y)25.15%
ROIC(3y)5.13%
ROIC(5y)17.09%
ROICexc(3y)7.07%
ROICexc(5y)35.47%
ROICexgc(3y)44.03%
ROICexgc(5y)78.19%
ROCE(3y)7.73%
ROCE(5y)25.78%
ROICexcg growth 3Y-35.35%
ROICexcg growth 5Y49.79%
ROICexc growth 3Y-58%
ROICexc growth 5Y39.27%
OM growth 3Y-38.55%
OM growth 5Y55.68%
PM growth 3Y-57.11%
PM growth 5Y-13.49%
GM growth 3Y-5.65%
GM growth 5Y7%
F-Score7
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.53
Debt/EBITDA 1.02
Cap/Depr 19.09%
Cap/Sales 2.11%
Interest Coverage 250
Cash Conversion 54.46%
Profit Quality 336.34%
Current Ratio 2.03
Quick Ratio 1.42
Altman-Z 3.84
F-Score7
WACC7.08%
ROIC/WACC0.6
Cap/Depr(3y)26.09%
Cap/Depr(5y)27.29%
Cap/Sales(3y)2.36%
Cap/Sales(5y)1.86%
Profit Quality(3y)322.49%
Profit Quality(5y)228.98%
High Growth Momentum
Growth
EPS 1Y (TTM)-59.16%
EPS 3Y-58.79%
EPS 5Y6.82%
EPS Q2Q%-34.78%
EPS Next Y31.82%
EPS Next 2Y34.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.4%
Revenue growth 3Y-5.77%
Revenue growth 5Y21.21%
Sales Q2Q%10.13%
Revenue Next Year22.03%
Revenue Next 2Y12.9%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.36%
EBIT growth 3Y-42.09%
EBIT growth 5Y88.7%
EBIT Next Year35.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40.8%
FCF growth 3Y-40.57%
FCF growth 5Y31.67%
OCF growth 1Y-37.6%
OCF growth 3Y-36.72%
OCF growth 5Y27.33%